Kevin Tidgewell

ORCID: 0000-0002-0501-2604
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Receptor Mechanisms and Signaling
  • Neuropeptides and Animal Physiology
  • Chemical synthesis and alkaloids
  • Marine Sponges and Natural Products
  • Pharmacological Receptor Mechanisms and Effects
  • Algal biology and biofuel production
  • Alkaloids: synthesis and pharmacology
  • X-ray Diffraction in Crystallography
  • Microbial Natural Products and Biosynthesis
  • Neuroscience and Neuropharmacology Research
  • Crystallization and Solubility Studies
  • Traditional and Medicinal Uses of Annonaceae
  • Cholinesterase and Neurodegenerative Diseases
  • Pharmacological Effects of Natural Compounds
  • Pain Mechanisms and Treatments
  • Neurotransmitter Receptor Influence on Behavior
  • Innovations in Medical Education
  • Traditional Chinese Medicine Analysis
  • Phytochemical compounds biological activities
  • Psychedelics and Drug Studies
  • Health and Medical Research Impacts
  • Hormonal and reproductive studies
  • Pain Management and Placebo Effect
  • Tryptophan and brain disorders
  • Crystallography and molecular interactions

Duquesne University
2014-2025

University of Kentucky
2024-2025

University of Pittsburgh
2017-2023

Smithsonian Tropical Research Institute
2012-2019

Mylan (United States)
2016-2018

Mylan (India)
2015

Scripps Institution of Oceanography
2009-2012

Oregon State University
2012

City of Knowledge
2012

University of California, San Diego
2010-2012

G protein-coupled receptor desensitization and trafficking are important regulators of opioid signaling that can dictate overall drug responsiveness in vivo. Furthermore, different μ-opioid (μOR) ligands lead to varying degrees regulation, presumably because distinct structural conformations conferred by agonist binding. For example, morphine binding produces a μOR with low affinity for β-arrestin proteins limited internalization, whereas enkephalin analogs promote robust both β-arrestins...

10.1124/mol.106.028258 article EN Molecular Pharmacology 2006-11-07

Structural modification of salvinorin A, the active component Salvia divinorum, has resulted in synthesis novel neoclerodane diterpenes with opioid receptor affinity and activity. We report this study a nonnitrogenous diterpene mu (13) that is an agonist at receptors. This represents identification structural class agonists.

10.1021/jm048963m article EN Journal of Medicinal Chemistry 2005-06-22

A collection of Lyngbya bouillonii from Palmyra Atoll in the Central Pacific, a site several thousand kilometers distant all previous collections this chemically prolific species cyanobacterium, was found to contain two new cancer cell cytotoxins apratoxin family. The structures compounds, apratoxins F and G, were determined by 1D 2D NMR techniques combination with mass spectrometric methods. Stereochemistry explored using chromatographic analyses hydrolytically released fragments optical...

10.1002/cbic.201000070 article EN ChemBioChem 2010-05-28

Tropical parasitic and infectious diseases, such as leishmaniasis, pose enormous global health threats, but are largely neglected in commercial drug discovery programs. However, the Panama International Cooperative Biodiversity Group (ICBG) has been working to identify novel treatments for malaria, Chagas' disease, leishmaniasis through an investigation of plants microorganisms from Panama. We have pursued activity-guided isolation extract Lyngbya majuscula that was found be active against...

10.1021/np900622m article EN Journal of Natural Products 2009-12-23

Four unsaturated polyketide lactone derivatives, coibacins A-D, were isolated from a Panamanian marine cyanobacterium, cf. Oscillatoria sp. The two different types of termini observed in these co-occurring metabolites, either methyl cyclopropyl ring as seen curacin A or vinyl chloride similar to that the jamaicamides, suggest an intriguing flexibility "beta branch" forming biosynthetic process. possess selective antileishmanial activity well potent anti-inflammatory activity.

10.1021/ol301607q article EN Organic Letters 2012-07-13

Marine cyanobacteria have gained momentum in recent years as a source of novel bioactive small molecules. This paper describes the structure elucidation and pharmacological evaluation two new, veraguamide O ( 1 ) P 2 ), one known, C( 3 analogs isolated from cyanobacterial collection made Las Perlas Archipelago Panama. We hypothesized that these compounds would be cytotoxic cancer cell lines. The were screened against HEK-293, estrogen receptor positive (MCF-7), triple-negative breast...

10.1101/2025.01.18.633713 preprint EN cc-by-nc bioRxiv (Cold Spring Harbor Laboratory) 2025-01-22

Marine cyanobacteria have gained momentum in recent years as a source of novel bioactive small molecules. This paper describes the structure elucidation and pharmacological evaluation two new (veraguamide O (1) veraguamide P (2)) one known C (3)) analogs isolated from cyanobacterial collection made Las Perlas Archipelago Panama. We hypothesized that these compounds would be cytotoxic cancer cell lines. The were screened against HEK-293, estrogen receptor positive (MCF-7), triple-negative...

10.3390/molecules30030680 article EN cc-by Molecules 2025-02-04

Rationale and Objective: The pain–depression dyad is highly prevalent has reciprocal psychological behavioral effects, leading to poor quality of life, increased disability, challenging therapeutic outcomes. In an attempt find better substances that can target comorbidity, we examined the effect aqueous (AE) ethanol (EE) extracts from Acacia sieberiana ( A. ) stem bark on reserpinized mice (female male Swiss albino aged 2‐3 months). Methods: was induced with 3 injections (Days 1–3) reserpine...

10.1155/adpp/1244498 article EN cc-by Advances in Pharmacological and Pharmaceutical Sciences 2025-01-01

Salvinorin A, a potent hallucinogen isolated from the leaves of Salvia divinorum, has gained popularity among adolescents in USA. No detailed study pharmacokinetics been conducted vivo. The present investigates vivo salvinorin A (0.032 mg/kg, i.v. bolus) rhesus monkeys (n = 4, 2 male, female). elimination t1/2 was rapid (56.6 ± 24.8 min) for all subjects. Pharmacokinetic differences (distribution t1/2, and AUC) were observed between males females, suggesting potential sex its pharmacologic...

10.1002/syn.20191 article EN Synapse 2005-01-01

Salvinorin A [(2<i>S</i>,4<i>aR</i>,6<i>aR</i>,7<i>R</i>,9<i>S</i>,10<i>aS</i>,10<i>bR</i>)-9-(acetyloxy)-2-(3-furanyl)-dodecahydro-6<i>a</i>,10<i>b</i>-dimethyl-4,10-dioxo-2<i>h</i>-naphtho[2,1-<i>c</i>]pyran-7-carboxylic acid methyl ester] is a hallucinogenic κ-opioid receptor agonist that lacks the usual basic nitrogen atom present in other known opioid ligands. Our first published studies indicated weakly inhibited μ-receptor binding, and subsequent experiments revealed partially...

10.1124/jpet.106.113167 article EN Journal of Pharmacology and Experimental Therapeutics 2006-10-23

Salvinorin A is a psychoactive natural product that has been found to be potent and selective κ opioid receptor agonist in vitro vivo. The activity of salvinorin unusual compared other opioids such as morphine it mediates signaling yet leads less downregulation than observed with agonists. Our initial chemical modifications have yielded one analogue, herkinorin (1c), high affinity at the μOR. We recently reported 1c does not promote recruitment β-arrestin-2 μOR or internalization. Here we...

10.1021/jm701162g article EN Journal of Medicinal Chemistry 2008-04-01

Fractionation of the extract marine cyanobacterium Lyngbya majuscula collected from Panama led to isolation malyngolide dimer (1). The planar structure 1 was determined using 1D and 2D NMR spectroscopy HRESI-TOFMS. absolute configuration established by chemical degradation followed chiral GC-MS analyses comparisons with an authentic sample seco-acid (4). Compound showed moderate in vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum (W2) (IC(50) = 19 microM) but...

10.1021/np9005184 article EN Journal of Natural Products 2010-02-16

[reaction: see text] Two new neoclerodane diterpenes, salvinicins A (4) and B (5), were isolated from the dried leaves of Salvia divinorum. The structures these compounds elucidated by spectroscopic techniques, including (1)H (13)C NMR, NOESY, HMQC, HMBC. absolute stereochemistry was assigned on basis single-crystal X-ray crystallographic analysis salvinicin a 3,4-dichlorobenzoate derivative salvinorin B.

10.1021/ol0510522 article EN Organic Letters 2005-06-15

This study focused on the in vivo effects of κ-opioid hallucinogen salvinorin A, derived from plant <i>Salvia divinorum</i>. The A (0.0032–0.056 mg/kg i.v.) were studied a neuroendocrine biomarker assay anterior pituitary hormone prolactin gonadally intact, adult male and female rhesus monkeys (<i>n</i> = 4 each). Salvinorin produced dose- time-dependent effects, similar to synthetic high-efficacy κ-agonist U69,593 ((+)-(5α,7...

10.1124/jpet.106.112417 article EN Journal of Pharmacology and Experimental Therapeutics 2006-10-23

Abstract Previous studies established that Tyr‐ D ‐Ala‐Gly‐N‐Me‐Phe‐Gly‐ol (DAMGO) and (2 S ,4a R ,6a ,7 ,9 ,10a ,10b )‐9‐(Benzoyloxy)‐2‐(3‐furanyl)dodecahydro‐6a,10b‐dimethyl‐4,10‐dioxo‐2 H ‐naphtho‐[2,1‐ c ]pyran‐7‐carboxylic acid methyl ester (herkinorin) are fully efficacious μ ‐agonists. Herkinorin (HERK), unlike DAMGO, does not recruit β‐arrestin promote ‐receptor internalization, even in cells over express β‐arrestin. We hypothesized chronic HERK DAMGO treatment will differentially...

10.1002/syn.20356 article EN Synapse 2006-12-06

Several neoclerodanes, such as salvinorin A (1) and herkinorin (3), have recently been shown to possess opioid receptor activity in vitro vivo. To explore the structure−affinity relationships of this interesting class compounds, we synthesized a series analogues from 1 isolated Salvia divinorum. Here, report semisynthesis neoclerodane diterpenes their at receptors. This work will allow further development novel ligands.

10.1021/np060094b article EN Journal of Natural Products 2006-05-26

Salvinorin A (1) is a hallucinogenic neoclerodane diterpene isolated from the widely available psychoactive plant Salvia divinorum and first example of non-nitrogenous opioid receptor ligand. At present, there little information as to why this compound selective for κ receptors. One approach better understanding mode binding 1 at receptors systematically alter structure examine effects on affinity activity. Currently, paucity methods described preparation analogues derived 1. Here, we report...

10.1021/np050398i article EN Journal of Natural Products 2005-12-22
Coming Soon ...